Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: A pH-metric comparison

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 1, 2002, Pages 35-39

  Frazzoni, M ^a   De Micheli, E ^a   Grisendi, A ^a   Savarino, V ^b  

^a Nuovo Ospedale S Agostino   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PH MEASUREMENT; PRIORITY JOURNAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; ANTI-ULCER AGENTS; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0036164221     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01138.x     Document Type: Article

References (29)

1. Long-term management of gastroesophageal reflux disease and its complications
2. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
3. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
4. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
5. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
6. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis
7. Heartburn - A serious symptom
8. Extraesophageal presentations of gastroesophageal reflux disease: An overview
9. Therapeutic approaches to healing esophagitis
10. Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland
11. Normal 24-hour ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender
12. A comparison of five maintenance therapies for reflux esophagitis
13. 13C-urea breath test
14. Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study
15. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy
16. Proton pump inhibitors for Barrett's oesophagus
17. Barrett's oesophagus and proton pump inhibitors: A pathological perspective
18. Overview of therapy for the extraesophageal manifestations of gastroesophageal reflux disease
19. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastrooesophageal reflux in patients with gastrooesophageal reflux disease
20. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
21. Approach to the patient with unexplained chest pain
22. ENT manifestations of gastroesophageal reflux
23. Asthma and gastroesophageal reflux
24. The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients
25. Dose-response relationship of lansoprazole to gastric acid antisecretory effects
26. Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer
27. Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial)
28. Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis
29. Variability in individual response to various doses of omeprazole